Chandler Chicco wins award for work on Botox migraine launch
pharmafile | May 27, 2011 | News story | Medical Communications | Chandler Chicco, awards, medical communications
Chandler Chicco Agency has won an award for its work on the launch of Botox’s chronic migraine indication in the UK.
The agency won the award in the pharmaceutical category at the recent Holmes Group EMEA Sabre Awards ceremony in Prague.
Allergan’s Botox is best known as a cosmetic treatment for smoothing out lines in the forehead, and the pharma company wanted to make sure its new licensed indication was fully understood by the media and the public.
Chandler Chicco says its campaign had a ‘huge responsibility’ to position Botox as a credible treatment for chronic migraine and to educate consumers on the therapeutic benefits of a drug.
The communications agency’s campaign reached an audience of more than 300 million, and produced 212 pieces of ‘on message’ coverage across national print, broadcast and online media.
Anne-Marie Rodriguez de Killeen, CCA’s managing director, said: “The seamless appearance of high profile, responsible and accurate media coverage was the result of meticulous planning and message development, the development of close working relationships with key stakeholders and smart media engagement.
“We’re delighted that to have been awarded the EMEA Sabre Awards for the pharmaceutical category in recognition of this campaign across Europe.”
Andrew McConaghie
Related Content
Synergy Vision MD appointed as trustee of the Cystic Fibrosis Trust
Managing director of Synergy Vision Ffyona Dawber has been appointed to the Cystic Fibrosis Trust’s …
The mutual benefit of becoming one of Britain’s best workplaces
Imagine a company with a 100%-satisfied workforce. What could a team of such fulfilled employees …
